Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Each month, hosts Keith Shaw and Matt Egan are joined by a top-tier panel of editors from Foundry’s global team to discuss hot technology topics and give insights from IT buyers in markets around the ...

Working It is the FT's workplace, future of work and leadership brand, led by Isabel Berwick. Sign up for Isabel's weekly Working It newsletter (here) which offers a sideways glance at the week's big ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

Discover the 10 biggest data breach fines and settlements of 2025. Explore GDPR penalties, global privacy regulations, and how billion-dollar enforcement actions impact cybersecurity and compliance ...